Clinical Trial Update: Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma [NA]

View source ↗

Summary

This document reports a completed clinical trial of molecular guided therapy for refractory or recurrent neuroblastoma, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Giselle Sholler | Conditions: Neuroblastoma | NA | Status: COMPLETED | Results posted: 2016-07-28